Navigation Links
MDS Pharma Services Expands Presence in Latin America with Sao Paulo Office
Date:1/28/2008

KING OF PRUSSIA, PA, Jan. 28 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has established an office in Sao Paulo, Brazil, to provide expanded capabilities in global clinical trial management. The new office joins nearly two dozen other MDS Pharma Services late stage clinical trial management offices in 21 countries in Africa, Asia Pacific, Europe, Latin America and North America. The opening of the Sao Paulo office is a clear indicator of the growing importance of Latin America to the drug development industry and of MDS Pharma Services' commitment to offer its clients the advantages of conducting trials in the region.

"Our new office in Sao Paulo is a key component of our global expansion strategy. It allows MDS Pharma Services to provide clients access to a large diverse pool of clinical trial participants and abundant healthcare resources, including more than 237,000 qualified physicians and more than 46,000 health institutions," said MDS Pharma Services President David Spaight. "Thanks to this excellent infrastructure, clinical trials in Brazil have an impressive track record of strong enrollment rates and good patient compliance and retention. These are critical factors in allowing us to fulfill the MDS Pharma Services brand promise to deliver high-quality, on-time service to clients."

In addition to the new office in Brazil, MDS Pharma Services also offers clinical trial monitoring services from Latin American offices in Buenos Aires, Argentina; Santiago, Chile; Lima, Peru; and Mexico City, Mexico. Since 2002, the MDS Pharma Services team in Latin America has conducted 33 global studies in focus areas such as oncology, metabolic disorders, cardiovascular, vaccines and infectious diseases.

Drug development activity has exploded in Brazil, which experienced a 1000 percent increase in clinical trials between 1995 and 2000. It is estimated that 645 Phase I-IV cl
'/>"/>

SOURCE MDS Pharma Services
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Millennium Treatment Group has recently noticed an ... level of drug use among teenagers. The treatment facility aims ... and work to minimize drug abuse. , America is currently ... addiction in history. According to the National Institute of ... aged 12 or older—or 9.2 percent of the population—had used ...
(Date:8/22/2014)... Amy Norton HealthDay Reporter ... growing number of Americans on work disability chronically use ... Researchers found that between 2007 and 2011, about 44 ... were prescribed narcotic painkillers each year. And the percentage ... 2007 to 23 percent in 2011. Experts ...
(Date:8/22/2014)... Many Americans know little about how Ebola is transmitted and ... the United States, a new survey shows. About four ... be a major Ebola outbreak in the United States, and ... will get sick with the deadly virus in the next ... poll. However, those opinions don,t match reality, the Harvard ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 Natural ... Kevin Richardson to restore his own vision from legally blind ... Michaels, prompting an investigative review. , “There is a ... or contacts for everyday function, and most people just think ... to corrective eye surgery that can be pretty risky at ...
(Date:8/22/2014)... DENVER Bcl-2-like protein 11 (BIM) deletion in ... with shorter progression free survival (PFS) in epidermal ... or chemotherapy treated Asian patients. Also, BIM deletion ... patients. , The BIM protein can activate the ... pathway in cells. BIM deletion has been detected ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2
... to new environments, scientists say , FRIDAY, Dec. 14 (HealthDay ... light on skin color changes in humans. , A ... gene that,s responsible for color differences in both species. , ... have little in common, they share many similarities, noted study ...
... Bowes Program Bolstered by Celebrity Support, WASHINGTON, ... grateful for supportive cards, especially during,the holiday season. ... to the,American Red Cross for delivery to hospitalized ... and his wife, Elizabeth, heard,about the program and ...
... Illinois smokers comply with new law, CHICAGO, Dec. 14 ... taking effect January 1. Smoke Free,Illinois makes it illegal to ... $250.00., Non-smokers are thrilled to get rid of those ... furious. Further forced into exile, smokers,can,t even huddle by the ...
... yoga one step further with,a personalized yoga mat. Introduced ... lovers the option to embroider their name, friend,s,name, or ... yoga mat., (Logo: http://www.newscom.com/cgi-bin/prnh/20071214/NYF023LOGO ), ... to offer more,options when choosing a yoga mat. "I ...
... and Lejon,Boudreaux are running a minimum of a marathon ... and tons of highway,debris to get a message across., ... to:, http://www.prnewswire.com/mnr/blackaidsinstitute/31094/ , "We want 1 million African ... National HIV Testing Day," says Sacco, 26, who came ...
... , FRIDAY, Dec. 14 (HealthDay News) -- Men whose mothers, ... in the BRCA1 or BRCA2 genes may also have the ... study finds. , Most of those men are unaware ... in Philadelphia, who examined how families discuss genetic test results. ...
Cached Medicine News:Health News:Fish Give Clues to Human Skin Color Changes 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 2Health News:Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members 3Health News:Smoke Free Illinois is a Positive Change 2Health News:Is Your Yoga Mat Lacking Personality? 2Health News:Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles 2Health News:Photo: Two Men Raising Awareness of HIV/AIDS by Running Minimum of a Marathon a Day from San Francisco to Los Angeles 3Health News:Breast Cancer Genes Also Raise Men's Risk for Malignancy 2
(Date:8/22/2014)... 2014 /CNW/ - On Aug. 20, at its annual ... Medical Association (CMA) voted on and approved a delegate ... medicinal cannabis. Bedrocan Cannabis Corp., a leading Canadian licensed ... motion. The CMA is quite right to ... smoking any plant material, including medicinal cannabis. While some ...
(Date:8/22/2014)... 22, 2014 MC Medical, a subsidiary of Mitsubishi ... Columbus, OH medical device company, have formally ... and robotic visualization system in Japan . ... in Japan in the latter half ... an extensive product portfolio in endoscopic surgery market in ...
(Date:8/22/2014)... Aug. 22, 2014 Research and Markets ... and Chinese Particulate Respirators Industry Report 2014" report ... Chinese Particulate Respirators Industry Report 2014 is a professional ... global particulate respirators industry with a focus on the ... of the industry including definitions, classifications, applications and industry ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Particulate Respirators Industry Report 2014 2
... Oct. 21 Sanofi-aventis announced today,that the ... (MHLW) has granted,approval for a Supplemental New ... coronary syndrome (unstable angina pectoris, non-ST elevation,myocardial ... being planned" for Plavix(R) (clopidogrel). Approximately ...
... Makes Cover of ... Molecular Cell, BUFFALO, N.Y., ... the structure,of the first mammalian GRP94 protein implicated in immune diseases such ... a,cover article in a top scientific journal -- Molecular Cell. Gewirth,s ...
Cached Medicine Technology:Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 2Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 3Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 4Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 5First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 2First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 3First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: